Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Volume 22, Issue 2, Pages 168-174Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00004347-200304000-00009
Keywords
ovarian cancer; prognosis; Rb; p21; cyclin E; p16
Categories
Ask authors/readers for more resources
To investigate the role of cell-cycle regulatory proteins in ovarian cancer, we performed immunohistochemistry for the cell-cycle promoters cyclin E and cyclin D2 and the cell-cycle inhibitors, Rb, p16(MTS1), p21(WAF1), and p27 K-IP1, in 93 ovarian carcinomas (77 with follow-up data). The results were correlated with clinicopathological parameters and the prognostic value was determined by multivariate analysis. Strong Rb and moderate-high cyclin E immunoreactivity in carcinomas were weakly associated with high expression of the proliferation marker Ki67. By Cox's multivariate analysis, advanced stage (p = 0.013), strong Rb expression (p = 0.006), and negative-weak p21 staining (p = 0.011) were independent prognostic indicators of short overall survival, indicating an apparently paradoxical role of the retinoblastoma protein in these tumors. In addition, trends pointing to an association of higher age (p = 0.067) and positive cyclin E immuntoreactivity (p = 0.093) with an unfavorable prognosis were observed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available